HOME >> MEDICINE >> NEWS
NIH convenes panel to assess evidence on chronic insomnia

The National Institutes of Health (NIH) will hold a State-of-the-Science Conference on the Manifestations and Management of Chronic Insomnia in Adults on June 13-15, 2005, at the Natcher Conference Center, on the NIH campus in Bethesda, MD. A press briefing will be held at the close of the conference, at 2:00 p.m. on Wednesday, June 15.

During the first day and part of the second day of the conference, experts will present the latest findings in the research of chronic insomnia to an independent panel. The panel will then meet in executive session to weigh the available scientific evidence and prepare its statement assessing the state of the science, to be presented for public comment at 9:00 a.m. on Wednesday, June 15.

Insomnia is the most common sleep complaint reported by women and men across all stages of adulthood and for many, the problem is chronic. While insomnia often exists simultaneously with other medical conditions (co-morbidities), the definitive etiology (cause) of insomnia remains unknown. Nevertheless, chronic insomnia is associated with a wide range of adverse consequences (morbidities), including depression, alcohol and drug abuse, difficulties with concentration and memory, and various cardiovascular, pulmonary, and gastrointestinal disorders. In addition to reduced quality of life and increased health care use reported by insomnia sufferers, the large number of people experiencing insomnia ultimately results in significant economic burden to society in lost productivity and health care costs. Although a number of promising behavioral and pharmacological approaches have recently been identified for the management of chronic insomnia symptoms, there has been limited guidance for clinicians in terms of choice of treatment.

The panel's statement will address these five key questions:

  • How is chronic insomnia defined, diagnosed, and classified, and what is known about its etiology?
  • What are the prevalenc
    '"/>


Contact: OMAR Information Center
nihcdp@mail.nih.gov
888-644-2667
NIH/Office of the Director
3-Jun-2005


Page: 1 2 3

Related medicine news :

1. American College of Physicians Foundation convenes conference
2. New Orleans levee report finished by panel including University of Texas at Austin engineer
3. IOF and EU panel prepare osteoporosis audit
4. RAND panel identifies key components of public health emergency preparedness
5. Medical, IT, engineering experts form advisory panel for electronic health record safety
6. SCAI expert panel sets high standards for PCI without on-site cardiac surgical backup
7. Conference on health communication call for papers and panel proposals
8. Consensus panel calls for expanded role of needle biopsies, MRI and less invasive procedures
9. Independent panel to evaluate a chemical used in some plastics for hazards to human health
10. Children need 60 minutes of daily physical activity, expert panel says
11. Children need 60 minutes of daily physical activity, expert panel says

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: NIH convenes panel assess evidence chronic insomnia

(Date:9/1/2015)... (PRWEB) , ... September 01, 2015 , ... The Jerry ... at The ACE Club and Green Valley Country Club in Lafayette Hill, PA. Over ... raised more than $13.5 million for programs and services designed to support patients and ...
(Date:9/1/2015)... , ... September 01, 2015 , ... ... the release of version 5.2 of the FirstSpirit Content Management System with new ... With the new version of FirstSpirit, companies will be well on their way ...
(Date:9/1/2015)... ... September 01, 2015 , ... The FSH Society , the Massachusetts-based charity ... (FSHD), will be the beneficiary of a collection of fundraising events this fall. From ... of the FSH Society and further FSHD research. , The list of ...
(Date:9/1/2015)... (PRWEB) , ... September 01, 2015 , ... ... and Qualification of Laboratory Instruments in accordance with GMP requirements“ , featuring Ed ... on October 6th, 2015 at 11:00 EDT (15:00 GMT). , Calibration, qualification, ...
(Date:9/1/2015)... York, NY (PRWEB) , ... September 01, 2015 ... ... that, to date, more than 1,500 investor-families have received permanent green cards (I-829 ... EB-5 projects. , The I-829 petition is the final step of the EB-5 ...
Breaking Medicine News(10 mins):Health News:The 26th Jerry Segal Classic Returns to Benefit Patients of Magee Rehabilitation Hospital 2Health News:The 26th Jerry Segal Classic Returns to Benefit Patients of Magee Rehabilitation Hospital 3Health News:e-Spirit boosts Corporate Content Cloud initiative with release of FirstSpirit 5.2 2Health News:e-Spirit boosts Corporate Content Cloud initiative with release of FirstSpirit 5.2 3Health News:FSH Society Beneficiary of Variety of Fall Fundraising Events 2Health News:FSH Society Beneficiary of Variety of Fall Fundraising Events 3Health News:Live Webinar from Pharmaceutical Technology and METTLER TOLEDO on Calibration and Qualification of Laboratory Instruments 2Health News:CanAm Enterprises Reaches Another Milestone with More Than 1,500 I-829 Petition Approvals 2
(Date:9/1/2015)... , Sept. 1, 2015  Abbott (NYSE: ABT ... a multi-center, randomized trial comparing the safety and effectiveness ... ® , Abbott,s market-leading, permanent drug eluting stent. ... Japan and enrolled 400 people with ... disease. The results will be featured at a late-breaking ...
(Date:9/1/2015)... , Sept. 1, 2015  Valeant Pharmaceuticals International, ... today announced that its affiliate has entered into ... was granted an exclusive license to develop and ... IL-17 receptor monoclonal antibody in development for patients ... the agreement, Valeant will hold the exclusive rights ...
(Date:8/31/2015)... Pepperl+Fuchs, a world leader in process ... leading provider of HART protocol devices. The move ... its integrated solutions offerings and strengthen its position ... are pleased to add the MACTek WirelessHART product ... Bolin , Pepperl+Fuchs, executive vice president of the ...
Breaking Medicine Technology:Abbott Announces Positive Results of Its Naturally Dissolving Stent from ABSORB Japan Study 2Abbott Announces Positive Results of Its Naturally Dissolving Stent from ABSORB Japan Study 3Abbott Announces Positive Results of Its Naturally Dissolving Stent from ABSORB Japan Study 4Valeant And AstraZeneca To Partner On Brodalumab 2Valeant And AstraZeneca To Partner On Brodalumab 3Valeant And AstraZeneca To Partner On Brodalumab 4
Cached News: